Siponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects
Gardin, Anne, Gray, Cathy, Neelakantham, Srikanth, Huth, Felix, Davidson, Antonia M., Dumitras, Swati, Legangneux, Eric, Shakeri-Nejad, KasraLanguage:
english
Journal:
European Journal of Clinical Pharmacology
DOI:
10.1007/s00228-018-2533-2
Date:
August, 2018
File:
PDF, 839 KB
english, 2018